Clinical Trials Sponsored by Cuorips Inc.

Total 35439 results

Osaka University
Cuorips Inc.

Recruiting

Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy

Myocardial Ischemia

Japan
Curis, Inc.

Recruiting

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

Germany, United States, Spain, Israel, Czechia, Poland, France, Italy
Curis, Inc.

Recruiting

A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma

Relapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System Lymphoma

United States, Spain, France, Czechia, Israel, Italy, Poland
Curis, Inc.

Completed

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Solid Tumor

United States, Australia
Curis, Inc.

Completed

Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations

Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations

United States, Spain
Curis, Inc.

Terminated

Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients

Cancer

United States
Curis, Inc.

Terminated

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma

Lymphoma

United States
Curis, Inc.

Completed

A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Non-Small Cell Lung Cancer | Liver Cancer

United States
Curis, Inc.

Completed

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Advanced Solid Tumors or Lymphomas

United States, Spain, Korea, Republic of, United Kingdom
Curis, Inc.

Completed

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

High-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline Carcinoma

United States
Curis, Inc.

Completed

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Head and Neck Cancer

United States
Curis, Inc.

Completed

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors

Tumors

United States
University of Leipzig
Curis, Inc.

Recruiting

Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948 (LUCAS)

Myelodysplastic Syndromes | Anemia

Germany
Dana-Farber Cancer Institute
Curis, Inc.

Active, not recruiting

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Lymphoma | Solid Tumor | Brain Tumor | Neuroblastoma

United States
Curis, Inc.
The Leukemia and Lymphoma Society

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditions

United States
FDA Office of Orphan Products Development
Curis, Inc.

Unknown

Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux

Vesicoureteral Reflux
WorldFish
Mercy Corps

Recruiting

Fish Consumption and Dietary Diversity in Timor-Leste

Dietary Deficiency

Timor-Leste
Medical Corps, Israel Defense Force

Completed

Video Head Impulse Test and Seasickness Susceptibility

Sea Sickness

Israel
Medical Corps, Israel Defense Force

Unknown

Meclizine Plasma Levels in Responders and Non-responders

Seasickness | Meclizine
Medical Corps, Israel Defense Force

Unknown

The Effect of Age and Inspiratory Resistance on the Inspiratory Gas Levels While Wearing Air Purifying Respirator "

Aging

Israel
Medical Corps, Israel Defense Force

Unknown

Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators

Musculoskeletal Disorders | Upper Extremity Pain Chronic

Israel
Medical Corps, Israel Defense Force

Unknown

Standardization of a Heat Tolerance Test for Young Women as a Basis for Heat Tolerance Tests in Female Soldiers

Heat Tolerance

Israel
Medical Corps, Israel Defense Force

Unknown

Dental Caries Management by Risk Assessment: Identification and Treatment of Risk Factors Among (IDF) Personnel (CAMBRA)

Dental Caries

Israel
Medical Corps, Israel Defense Force

Completed

Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees

Group A Streptococcus | Streptococcus Pneumonia | Carriage
Medical Corps, Israel Defense Force

Unknown

Efficacy of Various Treatments for Acute Acoustic Trauma.

Acute Acoustic Trauma

Israel
Medical Corps, Israel Defense Force

Unknown

Risk Factors for Hearing Loss as a Result of Exposure to Noise During Military Training in the IDF

Hearing Loss, Noise-Induced

Israel
Medical Corps, Israel Defense Force

Completed

Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.

Irritable Bowel Syndrome

Israel
Medical Corps, Israel Defense Force

Unknown

Assessment of HBV Vaccine Immunity After 18 Years

Hepatitis b Vaccine

Israel
Medical Corps, Israel Defense Force

Unknown

Heat Stress and Physiological Strain of Permeable vs. Impermeable CB Protective Garment

Heat Tolerance

Israel
Medical Corps, Israel Defense Force

Unknown

A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness

Simulator Sickness

Israel
Medical Corps, Israel Defense Force

Completed

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

Jarisch Herxheimer Reaction | Relapsing Fever, Tick-Borne

Israel
Medical Corps, Israel Defense Force

Recruiting

Assessment of Automatic Tourniquets for Soldiers During Wartime

Trauma Injury | Hemorrhage Wound

Israel
Medical Corps, Israel Defense Force

Not yet recruiting

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

Relapsing Fever, Tick-Borne
Medical Corps, Israel Defense Force

Completed

Seasickness Susceptability and Vestibular Time Constant

Seasickness

Israel
Medical Corps, Israel Defense Force

Completed

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Motion Sickness | Seasickness | Habituation | Vestibular Time Constant
Medical Corps, Israel Defense Force

Unknown

Motion Sickness Medications and Vestibular Time Constant

Drug Reaction

Israel
Medical Corps, Israel Defense Force

Completed

Assessing Foot Injuries in Infantry Recruits Wearing Different Boots

Back Pain | Blister | Ankle Sprain | Stress Fracture | Patellofemoral Pain Syndrome | Abrasion
Medical Corps, Israel Defense Force

Withdrawn

The Influence of an Intervention Program on Altering Health Behavioral Patterns Among IDF's Staff

Smoking Cessation | Weight Reduction | Physical Fitness Habits | Balanced Nutrition | Reduction of Stress

Israel
Medical Corps, Israel Defense Force

Unknown

The Affect of a Ventilated Helmet on Physiological Load

Physiological Strain

Israel
Medical Corps, Israel Defense Force

Unknown

Auxiliary Device to Alleviate Soldiers' Backload (minkal)

Physiological Strain of Weight Bearing.

Israel
Medical Corps, Israel Defense Force

Unknown

Staphylococcus Aureus Skin and Soft Tissue Infections

Staphylococcus Aureus

Israel
Medical Corps, Israel Defense Force

Unknown

Heat Intolerance- A Lesson From Global Genomic Response in Lymphocytes

Heat Intolerance | Gene Expression | Genotypic Variations | Genomic Markers for Predisposition of Heat Intolerance

Israel
Medical Corps, Israel Defense Force

Unknown

Impact of Work Environment Absent of Natural Light on Vitamin D Levels

Vitamin D Deficiency
Washington University School of Medicine
The Foundation for Barnes-Jewish Hospital; Curis, Inc.

Recruiting

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Stomach Cancer | Gastric Cancer | Esophageal Cancer | Gastroesophageal Junction Cancer | Esophagus Cancer

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
University of Chicago
Canine Therapy Corps

Recruiting

LH Canine Therapy Study

Emotion Regulation | Behavioral Disorder | Self Esteem

United States
Medical Corps, Israel Defense Force
Ariel University

Completed

The Effect of Functional Electrical Stimulation

Rupture of Anterior Cruciate Ligament

Israel
Medical Corps, Israel Defense Force
Ariel University

Unknown

The Influence of Dual Task and Gait Speed on Gait Variability in Patients With Chronic Ankle Instability

Chronic Instability of Joint

Israel
Tel Aviv University
Medical Corps, Israel Defense Force

Active, not recruiting

Neurological and Psychological Effects of Combat-Related Stress

Stress, Psychological | Stress Disorder, Posttraumatic

Israel
Sheba Medical Center
Medical Corps, Israel Defense Force

Unknown

Physiological Examination of New Fighting Clothing During Exposure to Exercise Under Hot Conditions

Clothing

Israel

Clinical Trials Sponsored by Cuorips Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations